Black Hawk Acquisition Corporation (BKHAU) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from May 31 2026 to May 31 2025 - CSIMarket
CSIMarket
 


Black Hawk Acquisition Corporation  (NASDAQ: BKHAU)


Black Hawk Acquisition's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Black Hawk Acquisition's ROI in the second quarter of 2026?
Black Hawk Acquisition Corporation achieved a return on average invested assets (ROI) of 1.79 % in its second quarter of 2026, this is above BKHAU's average return on investment of 1.6%.
Black Hawk Acquisition Corporation invested over the 12 months ending in its second quarter of 2026 $21 million

ROI decreased relative to the period ending Feb 28 2026, due to the decline in net income.

Within the Healthcare sector 170 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 2006 to 2040.

Definition and Formula of Return on Investment



Return On Investment (May 31 2026)
II. Quarter
(Feb 28 2026)
I. Quarter
(Nov 30 2025)
IV. Quarter
(Aug 31 2025)
III. Quarter
(May 31 2025)
II. Quarter
Y / Y Investment Change TTM -70.49 % -53.51 % -13.58 % 66.69 % 307.86 %
Y / Y Net Income Change TTM -86.52 % -68.87 % -31.69 % 74.52 % 805.13 %
Investment (TTM) in Millions 23 21 21 20 71
Return On Investment (TTM) 1.79 % 2.44 % 2.88 % 3.53 % 3.92 %
BKHAU's Overall Ranking # 2040 # 2006 # 1536 # 2141 # 1801
Seq. Investment Change TTM -36.38 % -27.9 % -21.8 % -17.74 % 0.23 %
Seq. Net Income Change TTM -53.22 % -39 % -36.23 % -25.92 % 8.05 %
Net Income (TTM) in Millions 0 1 1 2 3




Return On Investment BKHAU's Ranking
Within: No.
Industry # 16
Sector # 171
Overall # 2040

Return On Investment Statistics
High Average Low
2.88 %
1.6 %
0.23 %
(Nov 30 2025)   (Aug 31 2025)







Financial Statements
Black Hawk Acquisition's II. Quarter Investments $ 23 Millions BKHAU's Balance sheet
Black Hawk Acquisition's II. Quarter Income $ 0 Millions Quarterly BKHAU's Income Statement
BKHAU's Income by Division See BKHAU's Income by Division


BKHAU Annual Return On Investment (Nov 30 2025)
2025
(Nov 30 2024)
2024



Total Investments in Millions 21 72 0 0 0
Y / Y Investment Growth -71.46 % - - - -
Net Income in Millions 1 2 0 0 0
Y / Y Net Income Growth -30.6 % - - - -
Annual Return On Investment 6.46 % 2.66 % - - -


Annual Roi Comment
Despite deterioration in net income, company improved ROI to in the fiscal year 2025, company improved ROI to 6.46 % compare to previous year.

Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
BKHAU's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for BKHAU's Competitors
Subscribers only: Roi for Black Hawk Acquisition's Suppliers
Subscribers only: Return On Investment for BKHAU's Customers

Other Ratios
BKHAU's Roa BKHAU's Inventory Turnover Ratio BKHAU's Growth Rates BKHAU's Dividend Statistics
BKHAU's Profitability Ratios BKHAU's Asset Turnover Ratio BKHAU's Dividend Growth
BKHAU's Roe BKHAU's Valuation Ratios BKHAU's Financial Strength Ratios BKHAU's Dividend Payout Ratio



Companies with similar Return On Investment at May 31 2026, within Healthcare Sector ROI
Cadre Holdings inc   4.92 %
Haemonetics Corporation  4.91 %
The Pennant Group Inc   4.62 %
Vaso Corporation  4.40 %
Zimmer Biomet Holdings Inc   3.97 %
U S Physical Therapy Inc  3.91 %
Privia Health Group Inc   3.90 %
Integer Holdings Corporation  3.88 %
Ardent Health Inc   3.74 %
Collegium Pharmaceutical Inc   3.72 %
Merck and Co Inc   3.24 %
Community Health Systems Inc   3.12 %
National Vision Holdings Inc   2.99 %
Teva Pharmaceutical Industries Limited  2.66 %
Lifestance Health Group Inc   2.61 %
Conmed Corporation  2.57 %
Pfizer Inc  2.53 %
Mimedx Group Inc   2.38 %
Bio rad Laboratories Inc   2.34 %
Lifemd Inc   2.32 %
Alkermes Plc   2.31 %
Becton Dickinson And Company  2.22 %
Revvity Inc  2.18 %
Envista Holdings Corporation  2.06 %
Immucell Corporation  1.95 %
Atricure Inc   1.84 %
Black Hawk Acquisition Corporation  1.79 %
Omada Health Inc   1.70 %
Arvinas Inc   1.53 %
Repligen Corp  1.41 %


Date modified: 2026-09-19T05:04:51+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.